KeyCorp Lowers Doximity (NASDAQ:DOCS) Price Target to $65.00

Doximity (NASDAQ:DOCS) had its price target dropped by stock analysts at KeyCorp from $70.00 to $65.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s target price would suggest a potential upside of 18.33% from the company’s previous close.

Several other analysts have also issued reports on the company. Stephens assumed coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 target price for the company. Raymond James reaffirmed an “outperform” rating and set a $65.00 target price (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Bank of America boosted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research note on Monday. The Goldman Sachs Group assumed coverage on Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Finally, Robert W. Baird boosted their target price on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Thirteen investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $53.00.

Doximity Stock Down 1.0 %

Shares of DOCS stock opened at $54.93 on Wednesday. The business has a 50-day moving average price of $52.88 and a two-hundred day moving average price of $41.42. Doximity has a 12-month low of $22.96 and a 12-month high of $61.75. The firm has a market cap of $10.25 billion, a P/E ratio of 63.14, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38.

Institutional Investors Weigh In On Doximity

Hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC raised its holdings in Doximity by 20.6% in the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after purchasing an additional 296 shares in the last quarter. MetLife Investment Management LLC increased its stake in shares of Doximity by 0.6% in the 3rd quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after acquiring an additional 363 shares in the last quarter. First Horizon Advisors Inc. lifted its position in Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after acquiring an additional 384 shares during the period. Cornercap Investment Counsel Inc. boosted its stake in Doximity by 3.2% during the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after acquiring an additional 537 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the period. 87.19% of the stock is currently owned by institutional investors.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.